A healthcare company that provides a cheaper, faster, and more accurate solution to test for multiple proteins on a single patient sample.
Founded in 2012, PHASIQ enables efficient, accurate, and inexpensive measurement of multiple health-indicator proteins via phase-separated droplets. Their advantage is the ability to multiplex proteins not possible to measure simultaneously by other methods.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 17, 2015 | Series Unknown | — | 1 |
Zell Lurie Commercialization Fund
|
— | Detail |
| Mar 26, 2015 | Grant | $750K | 1 |
National Science Foundation
|
— | Detail |
| Jun 6, 2013 | Grant | $154.71K | 1 |
National Science Foundation
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Zell Lurie Commercialization Fund
|
Yes | Series Unknown |
National Science Foundation
|
Yes | Grant |